Germany's Merck hails cancer drug trial results (Reuters)


Reuters - Trials show that Merck KGaA's newly
launched cancer drug Erbitux slows the spread of rectal and
colon cancer and enables more patients to have surgery, the
German drug and chemical company said late on Saturday.

Read more...